BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 18, 2005
View Archived Issues
NovImmune, Serono Enter Antibody Deal Worth $122M
NovImmune SA entered its first product out-licensing pact, a deal with Serono SA, which is potentially worth up to $122 million for two preclinical fully human antibodies, NI-0401 and NI-0501. (BioWorld International)
Read More
To Increase Pipeline, CAT Pushing Back Profitability
Read More
Positive Results At ASCO For Nicotine Vaccine Raise Hopes
Read More
AC Immune Gets CHF21M For Sensitive Antibodie
Read More
Initiatives Aim To Make UK Top Spot For Clinical Trials
Read More
Intec Pharma Gets New CEO, Plans 'Accordion Pill' Program
Read More
Law On Agricultural Biotech Stuck In German Parliament
Read More
Other News To Note
Read More